Structural Simplification of Bedaquiline: the Discovery of 3-(4-(N,N-Dimethylaminomethyl)phenyl)quinoline-Derived Antitubercular Lead Compounds

详细信息    查看全文

• 作者：Dr. Chunxian He ; Dr. Laura Preiss ; Bin Wang ; Lei Fu ; Hui Wen ; Xiang Zhang ; Dr. Huaqing Cui ; Prof. Thomas Meier and Prof. Dali Yin
• 刊名：ChemMedChem
• 出版年：2017
• 出版时间：January 20, 2017
• 年：2017
• 卷：12
• 期：2
• 页码：106-119
• 全文大小：1350K
• ISSN：1860-7187

文摘

Bedaquiline (BDQ) is a novel and highly potent last-line antituberculosis drug that was approved by the US FDA in 2013. Owing to its stereo-structural complexity, chemical synthesis and compound optimization are rather difficult and expensive. This study describes the structural simplification of bedaquiline while preserving antitubercular activity. The compound's structure was split into fragments and reassembled in various combinations while replacing the two chiral carbon atoms with an achiral linkage instead. Four series of analogues were designed; these candidates retained their potent antitubercular activity at sub-microgram per mL concentrations against both sensitive and multidrug-resistant (MDR) Mycobacterium tuberculosis strains. Six out of the top nine MIC-ranked candidates were found to inhibit mycobacterial ATP synthesis activity with IC₅₀ values between 20 and 40 μm, one had IC₅₀>66 μm, and two showed no inhibition, despite their antitubercular activity. These results provide a basis for the development of chemically less complex, lower-cost bedaquiline derivatives and describe the identification of two derivatives with antitubercular activity against non-ATP synthase related targets.